You are here

Article Text

Article menu
Download PDFPDF
Letters
PostScript
Authors’ response
  1. S Borgquist,
  2. C Holm,
  3. M Stendahl,
  4. L Anagnostaki,
  5. G Landberg,
  6. K Jirström
  1. Institution of Laboratory Medicine, Division of Pathology, UMAS, Lund University, Sweden
  1. Dr K Jirström, Institution of Laboratory Medicine, Division of Pathology, UMAS, Lund University, Sweden; karin.jirstrom{at}med.lu.se

Statistics from Altmetric.com

    We appreciate the comments of Dr Speirs and can only agree that there are still several controversies to be solved regarding the specificity of ERβ-directed antibodies. In addition, the value of ERβ as a prognostic indicator and/or surrogate marker of tamoxifen treatment response in breast cancer …

    View Full Text

    Footnotes

    • Competing interests: None declared.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    2008 The BMJ Publishing Group and the Association of Clinical Pathologists

    Linked Articles